Literature DB >> 2998242

Prednisone inhibits late asthmatic reactions and the associated increase in airway responsiveness induced by toluene-diisocyanate in sensitized subjects.

L M Fabbri, P Chiesura-Corona, L Dal Vecchio, G R di Giacomo, E Zocca, N de Marzo, P Maestrelli, C E Mapp.   

Abstract

To determine whether late asthmatic reactions and the associated increase in airway responsiveness induced by toluene diisocyanate (TDI) are linked to airway inflammation, we investigated whether they are inhibited by prednisone. Ten "sensitized" subjects were studied in 2 sets of experiments. In the first set, each subject was given no treatment and was studied before and for 8 h after exposure to TDI. In the second set, 2 to 4 wk later, each subject was studied before treatment and then during treatment with prednisone (50 mg once a day for 3 days, orally), both before and after exposure to TDI. To assess late asthmatic reactions to TDI, we measured FEV1 immediately before and after exposure, then hourly for 8 h. To assess changes in airway responsiveness, we measured the provocation dose (mg) of methacholine causing a 20% decrease in FEV1 (PD20FEV1) before and 8 h after exposure to TDI. When the subjects received no prednisone treatment, TDI caused late asthmatic reactions and increased airway responsiveness. By contrast, when the subjects received prednisone, TDI caused no late asthmatic reaction or increased airway responsiveness. Prednisone did not change baseline airway caliber or airway responsiveness. These results suggest that late asthmatic reactions and the associated increase in airway responsiveness induced by TDI in "sensitized" subjects may depend on the development of a steroid-responsive acute inflammatory reaction within the airways.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998242     DOI: 10.1164/arrd.1985.132.5.1010

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

Review 1.  Leukocyte activation following IgE dependent mechanisms in bronchial asthma.

Authors:  S R Durham
Journal:  Clin Rev Allergy       Date:  1989

2.  Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives.

Authors:  O Vandenplas; J L Malo; M Saetta; C E Mapp; L M Fabbri
Journal:  Br J Ind Med       Date:  1993-03

3.  Stimulus-dependent glucocorticoid-resistance of GM-CSF production in human cultured airway smooth muscle.

Authors:  Thai Tran; Darren J Fernandes; Michael Schuliga; Trudi Harris; Linda Landells; Alastair G Stewart
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

4.  Specific bronchial reactivity to toluene diisocyanate: relationship with baseline clinical findings.

Authors:  P L Paggiaro; A Innocenti; E Bacci; O Rossi; D Talini
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

5.  Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate.

Authors:  S Finotto; L M Fabbri; V Rado; C E Mapp; P Maestrelli
Journal:  Br J Ind Med       Date:  1991-02

6.  Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs.

Authors:  S Sanjar; S Aoki; A Kristersson; D Smith; J Morley
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

Review 7.  Respiratory and other hazards of isocyanates.

Authors:  X Baur; W Marek; J Ammon; A B Czuppon; B Marczynski; M Raulf-Heimsoth; H Roemmelt; G Fruhmann
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

8.  Toluene diisocyanate induction of airway hyperresponsiveness at the threshold limit value (10 ppb) in rabbits.

Authors:  W Marek; J Potthast; B Marczynski; X Baur
Journal:  Lung       Date:  1995       Impact factor: 2.584

Review 9.  Advances in TRP channel drug discovery: from target validation to clinical studies.

Authors:  Ari-Pekka Koivisto; Maria G Belvisi; Rachelle Gaudet; Arpad Szallasi
Journal:  Nat Rev Drug Discov       Date:  2021-09-15       Impact factor: 112.288

Review 10.  The emerging role of transient receptor potential channels in chronic lung disease.

Authors:  Maria G Belvisi; Mark A Birrell
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.